A platform technology that enhances the cell permeability and RNA binding affinity of peptide nucleic acids (PNA) by introducing cationic lipid moieties, making it suitable for developing artificial nucleic acid therapeutics.

A non-opioid analgesic drug candidate currently in clinical trials, designed to provide pain relief without the use of opioids.